SOURCE: Merck & Co., Inc.DESCRIPTION:
Merck was named to the annual 100 Best Corporate Citizens ranking by 3BL. The list recognizes outstanding environmental, social and governance (ESG) transparency and performance. Assessed among 1,000 of the largest public U.S. companies, Merck ranked No. 1 in the Pharmaceuticals, Biotechnology & Life Sciences industry and No. 12 overall.
We are proud to be recognized for our ongoing commitment to operating responsibly as a company to drive long-term sustainability for our business, society and for the patients and communities we serve,” says Brenda Colatrella, associate vice president, corporate responsibility. “Our focus on ESG transparency and performance helps ensure we do the right thing for all our stakeholders.”
The 100 Best Corporate Citizens ranking is based on 146 ESG transparency and performance factors in eight pillars: climate change, employee relations, environment, finance, governance, human rights, stakeholders and society, and ESG performance.
The 100 Best Corporate Citizens debuted in 1999 in Business Ethics Magazine and appeared annually in Corporate Responsibility Magazine for many years. 3BL Media has managed the ranking since 2018. To compile the ranking, each company in the Russell 1000 Index is ranked according to its transparency and performance on 146 environmental, social and governance factors.
“Achieving the transformational targets in the Paris Agreement and UN Sustainable Development Goals in this decade requires all companies truly embed ESG issues into the core of their business,” said Dave Armon, CEO of 3BL Media. “The best corporate citizens of 2021 are answering the call by demonstrating the societal and bottom-line value of leadership and transparency around ESG topics. They are setting ambitious goals, outlining robust strategies for achieving them, disclosing data to measure progress, and accounting for all stakeholders in business decisions.”
Learn more about our company and our ESG commitments in our Corporate Responsibility Report.
KEYWORDS: Merk, NYSE:MRK